X0508 4 2024-01-25 0 0001672619 Enliven Therapeutics, Inc. ELVN 0001967168 Kintz Samuel C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD BOULDER CO 80301 1 1 0 0 President and CEO 1 Common Stock 2024-01-25 4 M 0 12000 1.12 A 12000 D Common Stock 2024-01-25 4 S 0 2542 14.9379 D 9458 D Common Stock 2024-01-25 4 S 0 9458 15.8868 D 0 D Common Stock 1087525 I See footnote Common Stock 88531 I See footnote Common Stock 88531 I See footnote Stock Option (right to buy) 1.12 2024-01-25 4 M 0 12000 0.00 D 2030-06-15 Common Stock 12000 284550 D The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. This transaction was executed in multiple trades at prices ranging from $14.35 to $15.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $15.35 to $16.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. The shares are held of record by an irrevocable trust dated October 26, 2021 for the benefit of the Reporting Person's elder son and for which the Reporting Person serves as an investment advisor. The shares are held of record by an irrevocable trust dated October 26, 2021 for the benefit of the Reporting Person's younger son and for which the Reporting Person serves as an investment advisor. The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. /s/ Ben Hohl, by power of attorney 2024-01-29